Portfolio of Genomics Stocks

Genomics includes agrigenomics, bacterial genomics, bioinformatics, cancer genomics, diagnostics, drug discovery, equipment, pharmacogenomics and research.

Here is a table of 10 genomics stocks.

10 Genomics Stocks

& Monthly Returns

& Snapshot

Recent Prices
& Trendline Chart

Agilent TechnologiesA
Alnylam PharmaceuticalsALNY
CRISPR TherapeuticsCRSP
Editas MedicineEDIT
Exact SciencesEXAS
Ionis PharmaceuticalsIONS
Myriad GeneticsMYGN
Sangamo TherapeuticsSGMO
Price charts from Alpha Vantage as of most recent close.

Portfolio Values

To inspect the performance of the Genomics Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 7 stocks included in the portfolio computations are: A, ALNY, EXAS, ILMN, MYGN, QGEN and SGMO. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 3 stocks excluded from the portfolio computations because of insufficient price data are: CRSP, EDIT and IONS.

The current value of a $10,000 investment is $47,963. The percent return is 379.63%. The annualized return is 36.83%.

Portfolio Value Chart for Last 100 Daily Closes

Values of User-Selected Sample Portfolios: Discover the Most and Least Profitable Sample Portfolios

Related Portfolios

Portfolio of Gene Editing (CRISPR) Stocks

Portfolio of Genetic Testing Stocks

Portfolio of Stem Cell Stocks